Epilepsi kliniske forsøg i Illinois
7 studier for Epilepsi søger deltagere på steder i Illinois.
Byer i Illinois
Officiel studietekst (engelsk)
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Lurie Children's Hospital of Chicago, Chicago
RekruttererFase 2
1 Day – 6 Months · Alle køn · Opdateret 2. okt. 2026 · NCT05104983Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT07594119A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Southern Illinois University School of Medicine, Springfield
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererObservationsstudie
Op til 26 år · Alle køn · Opdateret 6. aug. 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
RekruttererFase 3
1 Day – 18 Years · Alle køn · Opdateret 3. aug. 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 9. jun. 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 14. maj 2026 · NCT05716100Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.